Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Positive Breast Cancer
Status:
Completed
Trial end date:
2016-06-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy, such as docetaxel, doxorubicin , cyclophosphamide,
paclitaxel, and gemcitabine work in different ways to stop tumor cells from dividing so they
stop growing or die. Giving combination chemotherapy after surgery may kill any remaining
tumor cells.
PURPOSE: This randomized phase III trial is studying three different combination chemotherapy
regimens and comparing how well they work in treating women who have undergone surgery for
node-positive breast cancer.